Xuan Zeng Selected Research

de-Tyr(1)-Ala(2)- enkephalinamide-Leu

1/2017

Induction of Xa10-like Genes in Rice Cultivar Nipponbare Confers Disease Resistance to Rice Bacterial Blight.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xuan Zeng Research Topics

Disease

57	Neoplasms (Cancer) 01/2022 - 03/2005
9	Breast Neoplasms (Breast Cancer) 01/2022 - 03/2005
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020 - 07/2006
5	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2018
5	Lung Neoplasms (Lung Cancer) 01/2020 - 05/2008
4	Cough 01/2021 - 04/2018
4	Inflammation (Inflammations) 01/2020 - 04/2018
4	Adenocarcinoma of Lung 10/2019 - 07/2010
4	Adenocarcinoma 07/2015 - 07/2006
3	Carcinoma (Carcinomatosis) 07/2018 - 07/2006
3	Disease Resistance 03/2018 - 09/2015
3	Pancreatic Neoplasms (Pancreatic Cancer) 11/2010 - 12/2004
2	Bacterial Infections (Bacterial Infection) 05/2022 - 01/2017
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2022 - 01/2019
2	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2021 - 11/2019
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 10/2020 - 01/2020
2	Autoimmune Diseases (Autoimmune Disease) 01/2020 - 01/2020
2	Lymphatic Metastasis 01/2020 - 03/2017
2	Colorectal Neoplasms (Colorectal Cancer) 01/2019 - 07/2007
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2018 - 07/2006
2	Adrenocortical Adenoma (Disease, Conn's) 01/2014 - 11/2011
2	Chronic Pancreatitis 11/2010 - 02/2007
1	Tuberculosis (Tuberculoses) 01/2022
1	COVID-19 01/2022
1	Triple Negative Breast Neoplasms 01/2021
1	Antisocial Personality Disorder (Antisocial Personality) 01/2021
1	Microsatellite Instability 01/2021
1	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2021

Drug/Important Bio-Agent (IBA)

22	Proteins (Proteins, Gene)FDA Link 05/2022 - 03/2005
17	ParaffinIBA 01/2020 - 12/2004
14	Pharmaceutical PreparationsIBA 01/2021 - 06/2014
10	Formaldehyde (Formol)FDA Link 01/2020 - 07/2006
9	ErbB Receptors (EGF Receptor)IBA 06/2019 - 07/2006
8	Peptides (Polypeptides)IBA 01/2020 - 01/2013
6	Hyaluronic Acid (Hyaluronan)IBA 01/2020 - 02/2016
6	Silicon Dioxide (Silica)FDA LinkGeneric 01/2019 - 05/2015
4	Therapeutic UsesIBA 01/2022 - 01/2020
4	Metal-Organic FrameworksIBA 01/2021 - 01/2018
4	Immune Checkpoint InhibitorsIBA 01/2021 - 06/2019
4	Capsules (Microcapsules)IBA 01/2021 - 01/2015
4	Messenger RNA (mRNA)IBA 01/2020 - 11/2010
4	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2019 - 05/2015
4	LigandsIBA 03/2017 - 06/2010
4	DisulfidesIBA 01/2017 - 06/2010
4	DNA (Deoxyribonucleic Acid)IBA 05/2015 - 02/2007
3	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2021 - 01/2018
3	naoxintongIBA 01/2021 - 01/2019
3	Oxygen (Dioxygen)IBA 01/2021 - 01/2019
3	naringinIBA 01/2020 - 01/2019
3	Glutathione (Reduced Glutathione)IBA 01/2019 - 12/2017
3	tetracarboxyphenylporphineIBA 01/2019 - 09/2016
3	Transcription Activator-Like EffectorsIBA 03/2018 - 09/2015
3	Biomarkers (Surrogate Marker)IBA 01/2018 - 08/2009
2	Long Noncoding RNAIBA 01/2022 - 04/2018
2	Interleukin-10 (Interleukin 10)IBA 01/2022 - 01/2020
2	MetalsIBA 01/2022 - 01/2020
2	AntigensIBA 01/2022 - 01/2020
2	Biological ProductsIBA 01/2021 - 07/2018
2	Antineoplastic Agents (Antineoplastics)IBA 01/2021 - 05/2015
2	SolutionsIBA 01/2021 - 01/2018
2	Matrix Metalloproteinases (MMPs)IBA 01/2020 - 01/2015
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020 - 01/2018
2	FlavonoidsIBA 01/2020 - 04/2018
2	Photosensitizing Agents (Photosensitizers)IBA 01/2020 - 01/2018
2	CollagenIBA 01/2020 - 09/2006
2	RNA (Ribonucleic Acid)IBA 01/2020 - 10/2019
2	Anaplastic Lymphoma KinaseIBA 01/2020 - 07/2015
2	Glucose (Dextrose)FDA LinkGeneric 10/2019 - 01/2019
2	Hyaluronoglucosaminidase (Hyaluronidase)FDA Link 01/2019 - 03/2018
2	Polysaccharides (Glycans)IBA 01/2018 - 01/2016
2	Cell-Penetrating PeptidesIBA 02/2016 - 01/2013
2	AvidinIBA 01/2013 - 06/2010
1	p38 Mitogen-Activated Protein KinasesIBA 05/2022
1	MAP Kinase Kinase 6IBA 05/2022
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 05/2022
1	Calcium Carbonate (Limestone)FDA Link 01/2022
1	gluconic acid (gluconate)FDA LinkGeneric 01/2022
1	Glucose OxidaseIBA 01/2022
1	PerforinIBA 01/2022
1	Adenosine Triphosphate (ATP)IBA 01/2022
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2022
1	Nucleic AcidsIBA 01/2022
1	Nucleocapsid ProteinsIBA 01/2022
1	Biocompatible Materials (Biomaterials)IBA 01/2021
1	naringeninIBA 01/2021
1	Antitussive Agents (Antitussives)FDA Link 01/2021
1	Citric Acid (Citrate)FDA LinkGeneric 01/2021
1	PorphyrinsIBA 01/2021
1	B7-H1 AntigenIBA 01/2021
1	propylene diquat (PDQ(+))IBA 01/2021
1	Blood Glucose (Blood Sugar)IBA 10/2020

Therapy/Procedure

36	Therapeutics 01/2022 - 03/2005
7	Precision Medicine 01/2021 - 01/2016
7	Drug Therapy (Chemotherapy) 01/2020 - 09/2008
6	Photochemotherapy (Photodynamic Therapy) 01/2021 - 12/2017
4	Immunotherapy 01/2020 - 01/2018
3	Photothermal Therapy 01/2022 - 01/2018
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 11/2019 - 04/2018
1	Radiotherapy 01/2022
1	Subcutaneous Injections 10/2020